CompanyStageLast valuationTotal raised
665 Therapeutics, Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$6.7MAArtax Biopharma, Inc.Artax Biopharma, Inc., based in Cambridge, Massachusetts, develops immunomodulatory therapies for autoimmune diseases.Series AHealthcareLast valuationUndisclosedTotal raisedSign inAAthos Therapeutics, Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$10.3MCCASI Pharmaceuticals, Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MCCeleCor Therapeutics, Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$11.9MCCrossject SAPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$10.3MCCrosslink Therapeutics Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5.5MCCytoDyn Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$18.6MDDalCor Pharmaceuticals US, LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$7MGGridAI Technologies Corp.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5.3MKKIORA PHARMACEUTICALS INCKiora Pharmaceuticals develops EGP-437, a reformulated corticosteroid for inflammatory eye conditions.Series AHealthcareLast valuationUndisclosedTotal raisedSign inPPridCor Therapeutics, LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$6MTTelyRx Finco Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$12.6MTTELYRX HOLDINGS INC.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$12.6M